<?xml version="1.0" encoding="UTF-8"?>
<p>Somatic cell therapy products pertain to cell-based medicinal products (CBMPs) treatments. These products are extremely heterogeneous due to their origin, original harvested material, 
 <italic>in vitro</italic> handling degree and production process. These characteristics include the type of cell population and its stage of development or differentiation (embryonic or adult stem cells or early progenitor cells, induced pluripotent stem cells (IPSs) or differentiated cells).
</p>
